Comparison · NCT02969915-sae
Incentives vs Usual Care: serious adverse events
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. Incentives vs Usual Care: serious adverse events. Trial comparisons, record NCT02969915-sae. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT02969915-sae
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.0934 | 0.0776 | 0.112 | wilson | |
| Risk in group 2 | 0.104 | 0.0881 | 0.123 | wilson | |
| Risk difference, group 1 minus group 2 | -0.0108 | -0.0351 | 0.0137 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 0.896 | 0.7 | 1.15 | log | |
| Odds ratio, group 1 over group 2 | 0.886 | 0.673 | 1.16 | log | |
| Number needed to treat, for one fewer participant with a serious adverse event on Incentives than on Usual Care | 92.5 | from the risk difference interval | the interval includes no difference |
Source ClinicalTrials.gov
Groups2
Group 2 names the comparator: usual care.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | Incentives | Participants in the experimental arm have access to the ICC intervention and the incentive intervention~Incentives: Treatment incentives are offered to HIV-positive participants for reaching treatment targets, including retention to medical follow-up, initiating antiretroviral therapy, and maintaining high adherence with antiretroviral therapy.~Integrated Care Centers: ICCs offer key-population-oriented, vertically-integrated harm reduction, HIV testing, and HIV treatment services | 104 | 1,114 | EG000 |
| Group 2 | Usual Care | Participants in the active comparator arm have access to integrated care centers (ICCs)~Integrated Care Centers: ICCs offer key-population-oriented, vertically-integrated harm reduction, HIV testing, and HIV treatment services | 125 | 1,200 | EG001 |
Source ClinicalTrials.gov
Harm
- What it counts
- Total, serious adverse events
- Time frame
- 24 months
Source ClinicalTrials.gov
Trial
- Title
- Strategies to Improve the HIV Care Continuum Among Key Populations in India
- NCT number
- NCT02969915
- Phases
- NA
- Conditions
- HIV Infections
- Interventions
- Incentives, Integrated Care Centers
- Lead sponsor
- Johns Hopkins University
- Results first posted
- 2022-12-22
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT02969915?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT02969915-sae